← Back to Clinical Trials
Recruiting NCT07390318

NCT07390318 Bowel Continence Across the Lifespan in People With Spina Bifida

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07390318
Status Recruiting
Phase
Sponsor David Chu
Condition Spina Bifida
Study Type OBSERVATIONAL
Enrollment 943 participants
Start Date 2026-04-01
Primary Completion 2030-05-01

Eligibility & Interventions

Sex All sexes
Min Age 5 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Retrograde EnemaAntegrade Enema

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 943 participants in total. It began in 2026-04-01 with a primary completion date of 2030-05-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this observational study is to learn how different enema programs affect bowel control in children and adults with spina bifida. An enema program involves putting liquid into the large intestine (colon) to help someone poop. The main questions it aims to answer are: 1. How well do different enema programs prevent bowel accidents? 2. How do these enema programs affect independence, bowel symptoms, and quality of life? Researchers will compare two types of enema programs to see which works better and is easier for participants to manage. Participants starting a new enema program will answer online survey questions at 3 different timepoints over the course of 1 year.

Eligibility Criteria

Inclusion Criteria: * Minimum age 5 years old * Myelomeningocele diagnosis * Starting a retrograde or antegrade enema program (or switching from one enema program to the other) * English or Spanish speaking/literate Exclusion Criteria: \- Other types of spinal dysraphism (e.g., lipomyelomeningocele, fatty filum)

Contact & Investigator

Central Contact

Josephine Hirsch

✉ jahirsch@luriechildrens.org

📞 312-227-6076

Frequently Asked Questions

Who can join the NCT07390318 clinical trial?

This trial is open to participants of all sexes, aged 5 Years or older, studying Spina Bifida. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07390318 currently recruiting?

Yes, NCT07390318 is actively recruiting participants. Contact the research team at jahirsch@luriechildrens.org for enrollment information.

Where is the NCT07390318 trial being conducted?

This trial is being conducted at Birmingham, United States, Birmingham, United States, Phoenix, United States, Los Angeles, United States and 11 additional locations.

Who is sponsoring the NCT07390318 clinical trial?

NCT07390318 is sponsored by David Chu. The trial plans to enroll 943 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology